Advertisement
BGMS or CGEN or SNES
BGMS | CGEN | SNES | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 98 | 66 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 56 Fair valued | 43 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 20 | 99 | |
PRICE GROWTH RATING 1..100 | 77 | 62 | 92 | |
P/E GROWTH RATING 1..100 | 1 | 32 | 100 | |
SEASONALITY SCORE 1..100 | 2 | 45 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BGMS's Valuation (30) in the Biotechnology industry is in the same range as SNES (43) and is in the same range as CGEN (56). This means that BGMS's stock grew similarly to SNES’s and similarly to CGEN’s over the last 12 months.
BGMS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SNES (100) and is in the same range as CGEN (100). This means that BGMS's stock grew similarly to SNES’s and similarly to CGEN’s over the last 12 months.
CGEN's SMR Rating (20) in the Biotechnology industry is significantly better than the same rating for SNES (99) and is significantly better than the same rating for BGMS (100). This means that CGEN's stock grew significantly faster than SNES’s and significantly faster than BGMS’s over the last 12 months.
CGEN's Price Growth Rating (62) in the Biotechnology industry is in the same range as BGMS (77) and is in the same range as SNES (92). This means that CGEN's stock grew similarly to BGMS’s and similarly to SNES’s over the last 12 months.
BGMS's P/E Growth Rating (1) in the Biotechnology industry is in the same range as CGEN (32) and is significantly better than the same rating for SNES (100). This means that BGMS's stock grew similarly to CGEN’s and significantly faster than SNES’s over the last 12 months.
| BGMS | CGEN | SNES | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 81% | 1 day ago 75% |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 82% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 90% | 4 days ago 90% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 5 days ago 85% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 88% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 86% | 1 day ago 90% |
| Advances ODDS (%) | 9 days ago 87% | 10 days ago 83% | 5 days ago 75% |
| Declines ODDS (%) | 1 day ago 90% | 1 day ago 88% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 85% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 88% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BGMS’s FA Score shows that 2 FA rating(s) are green while CGEN’s FA Score has 2 green FA rating(s), and SNES’s FA Score reflects 0 green FA rating(s).
- BGMS’s FA Score: 2 green, 3 red.
- CGEN’s FA Score: 2 green, 3 red.
- SNES’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BGMS’s TA Score shows that 2 TA indicator(s) are bullish while CGEN’s TA Score has 4 bullish TA indicator(s), and SNES’s TA Score reflects 4 bullish TA indicator(s).
- BGMS’s TA Score: 2 bullish, 8 bearish.
- CGEN’s TA Score: 4 bullish, 6 bearish.
- SNES’s TA Score: 4 bullish, 4 bearish.
Price Growth
BGMS (@Building Products) experienced а -9.21% price change this week, while CGEN (@Biotechnology) price change was -9.40% , and SNES (@Chemicals: Specialty) price fluctuated +7.91% for the same time period.
The average weekly price growth across all stocks in the @Building Products industry was -0.48%. For the same industry, the average monthly price growth was -4.83%, and the average quarterly price growth was -4.60%.
The average weekly price growth across all stocks in the @Biotechnology industry was -2.45%. For the same industry, the average monthly price growth was -13.56%, and the average quarterly price growth was -4.32%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.33%. For the same industry, the average monthly price growth was -2.60%, and the average quarterly price growth was -0.39%.
Reported Earning Dates
BGMS is expected to report earnings on Nov 18, 2026.
CGEN is expected to report earnings on Nov 16, 2026.
SNES is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Building Products (-0.48% weekly)The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.
@Biotechnology (-2.45% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Chemicals: Specialty (-1.33% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MVRL | 9.51 | 0.22 | +2.32% |
| ETRACS Monthly Pay 1.5x Leveraged Mortgage REIT ETN (MVRL) | |||
| XSVM | 65.98 | 0.39 | +0.59% |
| Invesco S&P SmallCap Value with Momentum ETF (XSVM) | |||
| RBIL | 50.06 | 0.05 | +0.09% |
| F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL) | |||
| SRLN | 40.19 | -0.03 | -0.07% |
| State Street Blackstone Senior Loan ETF (SRLN) | |||
| NTSD | 47.19 | -0.25 | -0.52% |
| WisdomTree Efficient U.S. Plus International Equity Fund (NTSD) | |||